Haematologica EWOG-MDS website
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martini, G
Right arrow Articles by Lauria, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martini, G
Right arrow Articles by Lauria, F
Haematologica, Vol 91, Issue 12, 1720-1721
Copyright © 2006 by Ferrata Storti Foundation

Comparative Study

The effect of zoledronic acid on serum osteoprotegerin in early stage multiple myeloma

G Martini, A Gozzetti, L Gennari, A Avanzati, R Nuti, and F Lauria

We evaluated the effect of zoledronic acid (ZA) on serum levels of osteoprotegerin (OPG) and the ligand for receptor activator of nuclear factor kappaB (RANKL) in patients with smoldering myeloma. In treated subjects we found an increase of OPG accounting for an effect of ZA on osteoblast and/or bone marrow stromal cells together with the direct effect on osteoclasts.




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2006 by the Ferrata Storti Foundation.